Increased Secretory Leukocyte Protease Inhibitor (SLPI) Production by Highly Metastatic Mouse Breast Cancer Cells

Por Sayers, Kevin T., Brooks, Alan D., Sayers, Thomas J., Chertov, Oleg
Publicado em 2014

New flow cytometric assays for monitoring cell-mediated cytotoxicity

Por Zaritskaya, Liubov, Shurin, Michael R, Sayers, Thomas J, Malyguine, Anatoli M
Publicado em 2010

Differential effects of donor T-cell cytokines on outcome with continuous bortezomib administration after allogeneic bone marrow transplantation

Por Sun, Kai, Li, Minghui, Sayers, Thomas J., Welniak, Lisbeth A., Murphy, William J.
Publicado em 2008

Bortezomib sensitizes human renal cell carcinomas to TRAIL apoptosis via increased activation of caspase-8 in the death-inducing signaling complex

Por Brooks, Alan D., Jacobsen, Kristen M., Li, Wenqing, Shanker, Anil, Sayers, Thomas J.
Publicado em 2010

ELISPOT Assay for Monitoring Cytotoxic T Lymphocytes (CTL) Activity in Cancer Vaccine Clinical Trials

Por Malyguine, Anatoli M., Strobl, Susan, Dunham, Kimberly, Shurin, Michael R., Sayers, Thomas J.
Publicado em 2012

Impact of Dietary Components on NK and Treg Cell Function for Cancer Prevention

Por Kim, Young S., Sayers, Thomas J., Colburn, Nancy H., Milner, John A., Young, Howard A.
Publicado no Mol Carcinog (2015)

Antigen Presented by Tumors in Vivo Determines the Nature of CD8(+) T Cell Cytotoxicity

Por Shanker, Anil, Brooks, Alan D., Jacobsen, Kristen M., Wine, John W., Wiltrout, Robert H., Yagita, Hideo, Sayers, Thomas J.
Publicado em 2009

NKG2D Recognition and Perforin Effector Function Mediate Effective Cytokine Immunotherapy of Cancer

Por Smyth, Mark J., Swann, Jeremy, Kelly, Janice M., Cretney, Erika, Yokoyama, Wayne M., Diefenbach, Andreas, Sayers, Thomas J., Hayakawa, Yoshihiro
Publicado em 2004

Clerodane Diterpenes from Casearia arguta that Act as Synergistic TRAIL Sensitizers

Por Whitson, Emily L., Thomas, Cheryl L., Henrich, Curtis J., Sayers, Thomas J., McMahon, James B., McKee, Tawnya C.
Publicado em 2010

Bortezomib sensitizes human esophageal squamous cell carcinoma cells to TRAIL-mediated apoptosis via activation of both extrinsic and intrinsic apoptosis pathways

Por Seki, Naoko, Toh, Uhi, Sayers, Thomas J, Fujii, Teruhiko, Miyagi, Motoshi, Akagi, Yoshito, Kusukawa, Jingo, Kage, Masayoshi, Shirouzu, Kazuo, Yamana, Hideaki
Publicado em 2010

Differential effects of proteasome inhibition by bortezomib on murine acute graft-versus-host disease (GVHD): delayed administration of bortezomib results in increased GVHD-depende...

Por Sun, Kai, Wilkins, Danice E. C., Anver, Miriam R., Sayers, Thomas J., Panoskaltsis-Mortari, Angela, Blazar, Bruce R., Welniak, Lisbeth A., Murphy, William J.
Publicado em 2005

A cell-based high-throughput screen to identify synergistic TRAIL sensitizers

Por Booth, Nancy Lynn, Sayers, Thomas J., Brooks, Alan D., Thomas, Cheryl L., Jacobsen, Kristen, Goncharova, Ekaterina I., McMahon, James B., Henrich, Curtis J.
Publicado em 2008

Synergistic TRAIL sensitizers from Barleria alluaudii and Diospyros maritima()

Por Whitson, Emily L., Sun, Han, Thomas, Cheryl L., Henrich, Curtis J., Sayers, Thomas J., McMahon, James B., Griesinger, Christian, McKee, Tawnya C.
Publicado em 2012

Regulatory T Cells and Myeloid-Derived Suppressor Cells in the Tumor Microenvironment Undergo Fas-Dependent Cell Death during IL-2/αCD40 Therapy

Por Weiss, Jonathan M., Subleski, Jeff J., Back, Tim, Chen, Xin, Watkins, Stephanie K., Yagita, Hideo, Sayers, Thomas J., Murphy, William J., Wiltrout, Robert H.
Publicado em 2014

Identification of Human Neutrophil-derived Cathepsin G and Azurocidin/CAP37 as Chemoattractants for Mononuclear Cells and Neutrophils

Por Chertov, Oleg, Ueda, Hirotsugu, Xu, Luo Ling, Tani, Kenji, Murphy, William J., Wang, Ji Ming, Howard, O.M. Zack, Sayers, Thomas J., Oppenheim, Joost J.
Publicado em 1997

Induction of Tumor-specific T Cell Immunity by Anti-DR5 Antibody Therapy

Por Takeda, Kazuyoshi, Yamaguchi, Noriko, Akiba, Hisaya, Kojima, Yuko, Hayakawa, Yoshihiro, Tanner, Jane E., Sayers, Thomas J., Seki, Naoko, Okumura, Ko, Yagita, Hideo, Smyth, Mark J.
Publicado em 2004

Effects of cucurbitacins on cell morphology are associated with sensitization of renal carcinoma cells to TRAIL-induced apoptosis

Por Henrich, Curtis J., Thomas, Cheryl L., Brooks, Alan D., Booth, Nancy Lynn, Lowery, Evan M., Pompei, Richard J., McMahon, James B., Sayers, Thomas J.
Publicado em 2012

Anti-proliferative but not anti-angiogenic tyrosine kinase inhibitors enrich for cancer stem cells in soft tissue sarcoma

Por Canter, Robert J, Ames, Erik, Mac, Stephanie, Grossenbacher, Steven K, Chen, Mingyi, Li, Chin-Shang, Borys, Dariusz, Smith, Rachel C, Tellez, Joe, Sayers, Thomas J, Monjazeb, Arta M, Murphy, William J
Publicado em 2014

Bortezomib improves adoptive T cell therapy by sensitizing cancer cells to FasL cytotoxicity

Por Shanker, Anil, Pellom, Samuel T, Dudimah, Duafalia F, Thounaojam, Menaka C, de Kluyver, Rachel L, Brooks, Alan D, Yagita, Hideo, McVicar, Daniel W, Murphy, William J, Longo, Dan L, Sayers, Thomas J
Publicado no Cancer Res (2015)

Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib

Por Sun, Kai, Welniak, Lisbeth A., Panoskaltsis-Mortari, Angela, O'Shaughnessy, Matthew J., Liu, Haiyan, Barao, Isabel, Riordan, William, Sitcheran, Raquel, Wysocki, Christian, Serody, Jonathan S., Blazar, Bruce R., Sayers, Thomas J., Murphy, William J.
Publicado em 2004